ArticleThe Annals of thoracic surgery2026
Trends of Aortic Valve Replacement in Patients 65 Years and Younger in the United States.
Article in The Annals of thoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundCurrent guidelines recommend surgical aortic valve replacement (SAVR) over transcatheter aortic valve replacement (TAVR) for patients ≤65 years of age. Recent state-specific data suggest that >50% of patients aged ≤65 years undergo TAVR. Given recent data of a potential survival benefit for mechanical SAVR in patients aged 60 years and younger, we sought to evaluate the national incidence of TAVR, bioprosthetic SAVR, and mechanical SAVR in young patients.
methodsUsing the Premier Healthcare Database, all patients aged 40 to 65 years undergoing isolated aortic valve replacement (2016-2024) were assessed. Premier is a nationally representative all-payer, all-age, inpatient and outpatient database accounting for 25% of the population of the United States. Diagnosis-related group and International Classification of Diseases, Tenth Revision procedure codes were used to define procedures and comorbidities and a validated frailty metric.
resultsA total of 18,694 patients receiving first-time isolated aortic valve replacement were analyzed (31.3% TAVR, 68.7% SAVR). Patients receiving TAVR were older and more often female and Black, with higher Kim frailty index (P < .0001). Young patients were more likely to receive TAVR at teaching hospitals and larger centers (>499 beds). TAVR increased from the beginning of the study period to a peak of 40.8% in 2020, followed by a decrease to 32.5% in 2024. Overall utilization of mechanical SAVR remained between 15% and 18% throughout.
conclusionsNearly one-third of patients aged 40 to 65 years receive TAVR in contemporary practice. Real-time data highlight that evolving TAVR use outside of current guidelines is less than previously reported in regional data sets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.